ArticleBMC cancer2025

EGFR exon 20 insertions mutation in lung adenocarcinoma and its response by high-dose of Furmonertinib: a real-world study.

Sen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.